Hochschulschrift
Parenteral drug delivery systems based on fatty acid modified poly(glycerol adipate)
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Halle (Saale), Universitäts- und Landesbibliothek Sachsen-Anhalt, Diss., 2014
- Schlagwort
-
Arzneimittelentwicklung
Arzneimitteldesign
- Ereignis
-
Veröffentlichung
- (wo)
-
Halle, Saale
- (wer)
-
Universitäts- und Landesbibliothek Sachsen-Anhalt
- (wann)
-
2014
- Urheber
-
Weiss, Verena Maria
- Beteiligte Personen und Organisationen
- URN
-
urn:nbn:de:gbv:3:4-11894
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:53 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Beteiligte
- Weiss, Verena Maria
- Mäder, Karsten
- Kressler, Jörg
- Schulz-Siegmund, Michaela
- Universitäts- und Landesbibliothek Sachsen-Anhalt
Entstanden
- 2014
Ähnliche Objekte (12)
Fatty acid-modified poly(glycerol adipate) as a versatile matrix for parenteral depot formulations
Benefits of ω-3 fatty acids in parenteral nutrition
Supplementation of Ω-3 fatty acids in parenteral nutrition beneficially alters phospholipid fatty acid pattern
Glycerol‑bound oxidized fatty acids : formation and occurrence in peanuts
Oil-based parenteral depot formulation for veterinary peptide delivery
Poly(glycerol adipate) - indomethacin conjugates for modified drug release
Challenging controlled drug delivery : matrix systems for oral and parenteral application
Challenging controlled drug delivery : matrix systems for oral and parenteral application
In situ forming biodegradable microparticles for sustained parenteral delivery of protein drugs
Formulation and process development of biodegradable microparticles for controlled parenteral drug delivery
Formulation development of biodegradable implants for extended parenteral delivery of protein drugs
Formulation development of biodegradable implants for extended parenteral delivery of protein drugs
Fatty acid-modified poly(glycerol adipate) as a versatile matrix for parenteral depot formulations
Benefits of ω-3 fatty acids in parenteral nutrition
Supplementation of Ω-3 fatty acids in parenteral nutrition beneficially alters phospholipid fatty acid pattern
Glycerol‑bound oxidized fatty acids : formation and occurrence in peanuts
Oil-based parenteral depot formulation for veterinary peptide delivery
Poly(glycerol adipate) - indomethacin conjugates for modified drug release
Challenging controlled drug delivery : matrix systems for oral and parenteral application
Challenging controlled drug delivery : matrix systems for oral and parenteral application
In situ forming biodegradable microparticles for sustained parenteral delivery of protein drugs
Formulation and process development of biodegradable microparticles for controlled parenteral drug delivery
Formulation development of biodegradable implants for extended parenteral delivery of protein drugs
Formulation development of biodegradable implants for extended parenteral delivery of protein drugs
Fatty acid-modified poly(glycerol adipate) as a versatile matrix for parenteral depot formulations
Benefits of ω-3 fatty acids in parenteral nutrition
Supplementation of Ω-3 fatty acids in parenteral nutrition beneficially alters phospholipid fatty acid pattern
Glycerol‑bound oxidized fatty acids : formation and occurrence in peanuts
Oil-based parenteral depot formulation for veterinary peptide delivery
Poly(glycerol adipate) - indomethacin conjugates for modified drug release
Challenging controlled drug delivery : matrix systems for oral and parenteral application
Challenging controlled drug delivery : matrix systems for oral and parenteral application
In situ forming biodegradable microparticles for sustained parenteral delivery of protein drugs
Formulation and process development of biodegradable microparticles for controlled parenteral drug delivery
Formulation development of biodegradable implants for extended parenteral delivery of protein drugs